CRA consultants evaluate sales in Lanham Act dispute regarding alleged misrepresentations of bioequivalence

CRA consultants assessed whether disputed representations of bioequivalence significantly affected sales of the branded product. The evaluation included consideration of distribution channels, purchase timing, and the effect of payor control mechanisms on product uptake and sales. The case ultimately resulted in a settlement.

Meet our team